These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9316675)

  • 1. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.
    Gwirtsman HE; Szuba MP; Toren L; Feist M
    Psychopharmacol Bull; 1994; 30(2):157-64. PubMed ID: 7831449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on polytherapy with antidepressants and its significance in inpatients with major depression.
    Wada K; Yamada N; Hamamura T; Suzuki H; Nakano Y; Kuroda S
    Psychiatry Clin Neurosci; 1999 Oct; 53(5):557-62. PubMed ID: 10595679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression.
    Schmauss M; Laakmann G; Dieterle D
    J Clin Psychopharmacol; 1988 Apr; 8(2):108-11. PubMed ID: 3372705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
    Chan CH; Janicak PG; Davis JM; Altman E; Andriukaitis S; Hedeker D
    J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients.
    Joffe RT; Singer W
    Pharmacopsychiatry; 1990 Mar; 23(2):67-9. PubMed ID: 2339180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India.
    Sonawalla S; Chakraborty N; Parikh R
    J Indian Med Assoc; 2003 Feb; 101(2):116-7, 124. PubMed ID: 12841497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome.
    Papakostas GI; Petersen T; Pava J; Masson E; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Nerv Ment Dis; 2003 Jul; 191(7):444-9. PubMed ID: 12891091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J; Montes JM; Ibáñez A; Díaz M; Vicente F; Pelegrín C; Viñas R; Arias F; Carrasco JL; Ferrando L
    Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    Inoue T; Nakagawa S; Kitaichi Y; Izumi T; Tanaka T; Masui T; Kusumi I; Denda K; Koyama T
    J Affect Disord; 2006 Oct; 95(1-3):61-7. PubMed ID: 16797078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.
    Atmaca M; Kuloglu M; Tezcan E; Buyukbayram A
    Hum Psychopharmacol; 2003 Jun; 18(4):277-80. PubMed ID: 12766932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.